Summit Therapeutics Inc (SMMT)

12:15 PM

Griffin Asset Management Inc. Purchases 42,900 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

12:15 PM

Jan 31, 2025

Lightning Round: I don't want to sell Adobe down here, says Jim Cramer - MSN

Jan 31, 2025

Jan 30, 2025

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? - MSN

Jan 30, 2025

Jan 30, 2025

(SMMT) Investment Report - Stock Traders Daily

Jan 30, 2025

Jan 30, 2025

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? - The Motley Fool

Jan 30, 2025

Jan 30, 2025

Summit Therapeutics Inc. (NASDAQ:SMMT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 30, 2025

Jan 29, 2025

Is Summit Therapeutics Inc. (SMMT) the Unstoppable Stock to Buy in 2025? - Yahoo Finance

Jan 29, 2025

Jan 26, 2025

Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio? - Benzinga

Jan 26, 2025

Jan 26, 2025

Assenagon Asset Management S.A. Makes New $229,000 Investment in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat

Jan 26, 2025

Jan 26, 2025

Assenagon Asset Management S.A. Buys New Stake in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

Jan 26, 2025

Jan 26, 2025

Why Summit Therapeutics (SMMT) Is Skyrocketing Now - Insider Monkey

Jan 26, 2025

Jan 25, 2025

Summit Therapeutics (NASDAQ:SMMT) Stock Price Down 4.7%Time to Sell? - MarketBeat

Jan 25, 2025

Jan 25, 2025

Summit Therapeutics announces executive compensation changes - MSN

Jan 25, 2025

Jan 25, 2025

Summit Therapeutics retains Buy stock rating on clinical trial - MSN

Jan 25, 2025

Jan 24, 2025

Summit Therapeutics announces executive compensation changes By Investing.com - Investing.com Canada

Jan 24, 2025

Jan 24, 2025

Summit Therapeutics Grants Bonuses and Reports Strong Finances - TipRanks

Jan 24, 2025

Jan 22, 2025

Why Summit Therapeutics Stock Is Jumping Today - MSN

Jan 22, 2025

Jan 22, 2025

Cancer therapy’s new ‘gold rush’: bispecific antibodies that hit key combination of targets - STAT

Jan 22, 2025

Jan 22, 2025

HC Wainwright Reaffirms Buy Rating for Summit Therapeutics (NASDAQ:SMMT) - MarketBeat

Jan 22, 2025

Jan 22, 2025

Summit Therapeutics’ (SMMT) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jan 22, 2025

Jan 21, 2025

Summit Therapeutics' (SMMT) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Jan 21, 2025

Jan 21, 2025

Summit Therapeutics retains Buy stock rating on clinical trial By Investing.com - Investing.com Canada

Jan 21, 2025

Jan 20, 2025

12 Hot Stocks to Buy According to Analysts - Insider Monkey

Jan 20, 2025

Jan 20, 2025

Here’s Why Analysts Are Bullish on Summit Therapeutics Inc. (SMMT) - Yahoo Finance

Jan 20, 2025

Jan 20, 2025

Long Term Trading Analysis for (SMMT) - Stock Traders Daily

Jan 20, 2025

Jan 19, 2025

JPMorgan Chase & Co. Sells 1,101 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

Jan 19, 2025

Jan 18, 2025

Is Summit Therapeutics (SMMT) the Best Russell 2000 Stock to Invest in According to Analysts? - MSN

Jan 18, 2025

Jan 18, 2025

Summit Therapeutics (SMMT) Stock Price, News & Analysis - MarketBeat

Jan 18, 2025

Jan 18, 2025

Summit Therapeutics (NASDAQ:SMMT) Trading 6.5% HigherWhat's Next? - MarketBeat

Jan 18, 2025

Jan 18, 2025

Summit Therapeutics: Data Signals A Potential Paradigm Shift In NSCLC (Rating Upgrade) - Seeking Alpha

Jan 18, 2025

Jan 17, 2025

Summit Therapeutics (NASDAQ:SMMT) Trading Down 6.3%Here's What Happened - MarketBeat

Jan 17, 2025

Jan 17, 2025

Looking At Summit Therapeutics's Recent Unusual Options Activity - Benzinga

Jan 17, 2025

Jan 17, 2025

24,879 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Bought by SeaCrest Wealth Management LLC - MarketBeat

Jan 17, 2025

Jan 16, 2025

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jan 16, 2025

Jan 16, 2025

Summit Therapeutics (SMMT) Stock Surge Driven by Promising Drug Trials - GuruFocus.com

Jan 16, 2025

Jan 15, 2025

Why Summit Therapeutics Rocketed 584% in 2024 - MSN

Jan 15, 2025

Jan 13, 2025

Summit Therapeutics Highlights Success at Healthcare Conference - TipRanks

Jan 13, 2025

Jan 10, 2025

Summit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News Summary - Benzinga

Jan 10, 2025

Jan 09, 2025

(SMMT) Technical Data - Stock Traders Daily

Jan 09, 2025

Jan 08, 2025

Summit Therapeutics (NASDAQ:SMMT) Shares Up 3.3%Should You Buy? - MarketBeat

Jan 08, 2025

Jan 08, 2025

Merck rival Summit draws new buy from Truist on deal prospects - Seeking Alpha

Jan 08, 2025

Jan 08, 2025

Summit Therapeutics (NASDAQ:SMMT) Now Covered by Analysts at Truist Financial - MarketBeat

Jan 08, 2025

Jan 07, 2025

Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside - Benzinga

Jan 07, 2025

Jan 07, 2025

Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 07, 2025

Jan 05, 2025

SA Asks: Which biotechs are most likely to be acquired near-term? - Seeking Alpha

Jan 05, 2025